{
    "title": "RSS Feed Title",
    "link": "https://example.com",
    "description": "RSS Feed Description",
    "lastBuildDate": "2025-05-12T17:42:36.554385",
    "items": [
        {
            "title": "Swiggy Q4 FY25: Growth on the table, Quick Commerce remains a drag",
            "link": "https://www.moneycontrol.com/news/business/earnings/swiggy-q4-fy25-growth-on-the-table-quick-commerce-remains-a-drag-13020630.html",
            "description": "The company continues to deliver strong top-line growth, but continued investment in Quick Commerce and rising competitive intensity are weighing on margins.",
            "pubDate": "2025-05-12T05:45:56.426826"
        },
        {
            "title": "SBI-Sumitomo deal for Yes Bank \u2013 Who gains the most?",
            "link": "https://www.moneycontrol.com/news/business/earnings/sbi-sumitomo-deal-for-yes-bank-who-gains-the-most-13020560.html",
            "description": "The deal makes the bank a winner",
            "pubDate": "2025-05-12T05:45:56.426911"
        },
        {
            "title": "Navin Fluorine: Multiple agreements, new capacities strengthen outlook",
            "link": "https://www.moneycontrol.com/news/business/earnings/navin-fluorine-multiple-agreements-new-capacities-strengthen-outlook-13020568.html",
            "description": "The company could benefit from the China-plus-one theme in fluorine chemistry",
            "pubDate": "2025-05-12T05:45:56.426980"
        },
        {
            "title": "Indo-Pak Ceasefire: What\u2019s next for Indian equities?",
            "link": "https://www.moneycontrol.com/news/business/markets/indo-pak-ceasefire-what-s-next-for-indian-equities-13020537.html",
            "description": "Volatility may continue in the short term and it\u2019s better to be watchful",
            "pubDate": "2025-05-12T05:45:56.427052"
        },
        {
            "title": "UK FTA can help Indian IT manage costs better, but no immediate earnings boost",
            "link": "https://www.moneycontrol.com/news/opinion/uk-fta-can-help-indian-it-manage-costs-better-but-no-immediate-earnings-boost-13020542.html",
            "description": "The free trade agreement (FTA) does not propose changes to visas or immigration policies",
            "pubDate": "2025-05-12T05:45:56.427134"
        },
        {
            "title": "Govt sacks SECI CMD RP Gupta amid raft of controversies",
            "link": "https://www.moneycontrol.com/news/business/govt-sacks-seci-cmd-rp-gupta-amid-raft-of-controversies-13021099.html",
            "description": "It could be incidental, but the order came a week after Prime Minister Narendra Modi met Andhra Pradesh chief minister N Chandrababu Naidu, a state which was mentioned in the US SEC's indictment of the Adani group for alleged bribery to secure power purchase agreements for solar energy.",
            "pubDate": "2025-05-12T11:55:49.519418"
        },
        {
            "title": "NCLAT dismisses insolvency plea against PepsiCo India",
            "link": "https://www.moneycontrol.com/news/business/companies/nclat-dismisses-insolvency-plea-against-pepsico-india-13021637.html",
            "description": "The appellate insolvency tribunal has upheld the earlier order passed by the Chandigarh bench of the National Company Law Tribunal (NCLT), which had rejected SNJ Synthetics\u2019s plea",
            "pubDate": "2025-05-12T14:41:42.643258"
        },
        {
            "title": "Tata Steel profit jumps 117% to Rs 1,201 crore in Q4FY25, declares dividend of Rs 3.60",
            "link": "https://www.moneycontrol.com/news/business/earnings/tata-steel-profit-jumps-117-to-rs-1-201-crore-in-q4fy25-13021620.html",
            "description": "The company\u2019s revenue fell 4.2 percent to Rs 56,218.11 crore in the reported quarter compared to Rs 58,687.31 crore in the year-ago period, the filing said",
            "pubDate": "2025-05-12T14:41:42.643360"
        },
        {
            "title": "Cautious Indian pharma awaits clarity on Trump\u2019s prescription drug plan",
            "link": "https://www.moneycontrol.com/news/business/companies/cautious-indian-pharma-awaits-clarity-on-trump-s-prescription-drug-plan-13021504.html",
            "description": "Indian generic drugmakers typically operate on thin EBITDA margins of 5-15 percent on average for their base business in US, and even a small reduction in price could lead to financial unviability.",
            "pubDate": "2025-05-12T14:41:42.643439"
        },
        {
            "title": "Trump signs order to slash US drug prices using global benchmarking, lacks clarity on generic drugs",
            "link": "https://www.moneycontrol.com/news/business/companies/trump-signs-order-to-slash-us-drug-prices-using-global-benchmarking-lacks-clarity-on-generic-drugs-13021700.html",
            "description": "India, which supplies nearly 40% of U.S. generics, exported $8.73 billion worth of drugs to the U.S. in 2024. Any disruption in pricing would eat into the already thin profit margins.",
            "pubDate": "2025-05-12T17:42:35.797686"
        }
    ]
}